查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1953929

蛋白質純化與分離市場－全球產業規模、佔有率、趨勢、機會及預測（依應用、產品、技術、地區及競爭格局分類，2021-2031年）

Protein Purification and Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Product, By Technology, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球蛋白質純化和分離市場預計將從 2025 年的 91.7 億美元成長到 2031 年的 161.8 億美元，複合年成長率為 9.93%。

該領域涵蓋電泳和層析法等關鍵技術，用於從複雜混合物中提取特定蛋白質，以用於治療和研究目的。市場的主要驅動力是需要生物療法的慢性疾病發生率不斷上升，以及生物製藥生產能力的相應成長。這些因素持續推動對純化技術的需求，以確保原料藥的安全性和純度，從而成為推動產業成長的核心動力，即使市場存在暫時性波動。

市場概覽
預測期 2027-2031
市場規模：2025年 91.7億美元
市場規模：2031年 161.8億美元
複合年成長率：2026-2031年 9.93%
成長最快的細分市場 裝置
最大的市場 北美洲

市場擴張的主要障礙之一是先進純化設備所需的大量初始投資，這限制了小規模研究機構獲得此類設備的機會。該行業的高財務風險也反映在推動採購需求的區域投資趨勢中。根據歐洲製藥工業協會聯合會 (EFPIA) 的報告，歐洲製藥業計劃在 2024 年投入約 550 億歐元用於研發，凸顯了該領域投入的大量資源。

市場促進因素

生物製藥和生物製藥市場的擴張是推動該產業發展的關鍵因素。隨著製藥開發商日益重視生物療法，他們越來越依賴下游製程來滿足嚴格的純度要求。根據美國食品藥物管理局(FDA) 於 2024 年 1 月發布的《2023 年新藥核准情況報告》，已有 55 種新分子實體 (NME) 獲得核准，這凸顯了治療創新步伐的加快，而這需要強大的分離通訊協定。生物製藥核准的增加與層析管柱和純化樹脂採購量的成長直接相關。例如，賽默飛世爾科技 (Thermo Fisher Scientific) 在 2024 年 1 月發布的 2023 會計年度財報中公佈的 428.6 億美元年收入，就體現了支持基礎設施的規模之大，也展現了生命科學服務和工具市場的巨大潛力。

此外，生命科學領域研發投入的增加推動了產業成長，使實驗室能夠購買先進設備。持續的資金投入有助於抵消自動化純化系統的高成本，使實驗室能夠更新工作流程並採用高通量技術。這筆資金對於縮短藥物研發週期和提高營運效率至關重要。根據美國藥品研究與製造商協會 (PhRMA) 於 2024 年 8 月發布的《2024 年 PhRMA 會員調查報告》，預計會員公司在 2023 年的研發支出將達到 1,035 億美元。這項巨額投資確保了對分離生物標記和治療性蛋白質所需的資本設備和耗材的持續需求。

市場挑戰

全球蛋白質純化和分離市場的一大障礙是先進純化設備所需的高昂初始投資成本。這一經濟壁壘限制了小規模的研究中心、學術機構和新興生物技術公司的進入，因為它們不像大型製藥公司那樣財力雄厚。由於這些小規模機構對科學進步和早期藥物發現至關重要，它們無法獲得必要的純化系統會阻礙研究進展，並降低整個產業的設備普及率。

近期產業資金籌措的波動加劇了這些資金限制的影響，嚴重削弱了小規模企業的購買力。根據生技創新局的數據，到2025年，生技Start-Ups的資金籌措從第一季的26億美元驟降至第二季的9億美元。可用資金的減少迫使新興企業推遲或放棄對關鍵分離技術的投資。因此，這些關鍵終端用戶的資金短缺造成了需求瓶頸，儘管科學界對這些儀器有著明確的需求，但市場成長卻因此放緩。

市場趨勢

一次性淨化技術的廣泛應用正在變革生產流程，它無需進行複雜的清潔驗證，並降低了交叉污染的風險。越來越多的合約研發生產機構（CDMO）正從傳統的不銹鋼設備轉向靈活的一次性系統，以管理多樣化的生物產品線，這一趨勢尤其明顯。這種轉變使工廠能夠更快地切換產品線，提高產能運轉率並降低用水量。例如，無錫生物製藥在2024年6月的新聞稿中宣布，將在其杭州工廠安裝三台新的5000公升一次性生物反應器，將其總產能從8000公升擴大到23000公升，以滿足全球需求，這體現了其對可擴展一次性基礎設施的承諾。

同時，人工智慧在製程最佳化的應用正在變革純化通訊協定的設計與執行。透過利用先進的機器學習演算法，製造商可以預測理想的層析法和過濾設置，從而顯著減少製程開發所需的實驗工作量。這種數位化變革實現了分離單元的即時監控和自適應控制，確保產品品質的穩定性並降低產量損失。隨著企業尋求改善營運並做出數據驅動的決策，整個產業向這些數位化工具的轉型正在加速。根據Benchling於2024年11月發布的《2024年生物製藥技術趨勢報告》，67%的領先生物製藥公司正在採用人工智慧和機器學習來增強其研發能力。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章：全球蛋白質純化與分離市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依應用領域（藥物篩檢、生物標記發現、蛋白質-蛋白質交互作用研究、診斷）
    • 依產品分類（設備、耗材）
    • 透過技術（超過濾、沉澱、層析法、電泳、蛋白質印跡等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美蛋白質純化與分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲蛋白質純化與分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區蛋白質純化與分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲蛋白質純化分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲蛋白質純化與分離市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球蛋白質純化與分離市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • QIAGEN NV
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • GE HealthCare Technologies Inc.
  • Promega Corporation
  • Norgen Biotek Corp.
  • Abcam Limited
  • Danaher Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23915

The Global Protein Purification and Isolation Market is projected to expand from USD 9.17 Billion in 2025 to USD 16.18 Billion by 2031, reflecting a CAGR of 9.93%. This sector encompasses critical techniques such as electrophoresis and chromatography, which are utilized to extract specific proteins from complex mixtures for therapeutic and research purposes. The market is largely driven by the rising incidence of chronic diseases necessitating biologic treatments and the associated growth in biopharmaceutical manufacturing capabilities. These factors generate a persistent need for purification technologies to guarantee the safety and purity of drug substances, serving as the core engine for industry growth regardless of transient market shifts.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 9.17 Billion
Market Size 2031USD 16.18 Billion
CAGR 2026-20319.93%
Fastest Growing SegmentInstruments
Largest MarketNorth America

One major obstacle to market expansion is the substantial initial capital investment required for sophisticated purification instruments, which limits availability for smaller research entities. The high financial stakes of the industry are mirrored in regional investment trends that fuel these procurement demands. As reported by the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical sector in Europe allocated approximately €55,000 million toward research and development in 2024, highlighting the significant resources directed into this field.

Market Driver

The expansion of the biopharmaceutical sector and the biologics market acts as a major catalyst for this industry. As pharmaceutical developers increasingly prioritize biological therapies, the reliance on downstream processing grows to satisfy rigorous purity requirements. Data from the U.S. Food and Drug Administration's 'Novel Drug Approvals for 2023' report in January 2024 indicates the approval of 55 new molecular entities, underscoring the quickening rate of therapeutic innovation that demands strong isolation protocols. This increase in biologic approvals is directly linked to higher purchases of chromatography columns and purification resins. Demonstrating the magnitude of the supporting infrastructure, Thermo Fisher Scientific reported in their January 2024 press release regarding full-year 2023 results that they achieved $42.86 billion in annual revenue, indicating the substantial volume of the market for life sciences services and tools.

Furthermore, rising investment in life sciences research and development drives growth by allowing laboratories to purchase advanced equipment. Continuous funding helps offset the high expense of automated purification systems, enabling facilities to update their workflows and adopt high-throughput technologies. This capital flow is crucial for shortening drug development schedules and improving operational efficiency. As noted by the Pharmaceutical Research and Manufacturers of America in their '2024 PhRMA Annual Membership Survey' published in August 2024, member firms spent $103.5 billion on R&D in 2023. This massive financial commitment guarantees ongoing demand for the capital equipment and consumables needed to isolate biomarkers and therapeutic proteins.

Market Challenge

A major obstacle hindering the Global Protein Purification and Isolation Market is the substantial upfront capital cost needed for sophisticated purification instruments. This financial barrier limits entry for smaller research centers, academic bodies, and startup biotechnology companies, which typically do not possess the extensive funds available to large pharmaceutical enterprises. Because these smaller organizations are vital for scientific advancement and early drug discovery, their inability to acquire necessary purification systems hampers research progress and decreases the overall rate of equipment adoption within the sector.

The impact of these financial limitations is exacerbated by recent volatility in sector funding, which severely restricts the buying power of smaller players. Data from the Biotechnology Innovation Organization indicates that in 2025, funding for biotech startups fell from $2.6 billion in the first quarter to just $900 million in the second. This reduction in available capital forces emerging firms to postpone or abandon investments in essential isolation technologies. As a result, the lack of liquidity among these crucial end-users causes a demand bottleneck, slowing market growth despite the clear scientific need for these instruments.

Market Trends

The extensive uptake of single-use purification technologies is transforming manufacturing processes by removing the necessity for intricate cleaning validation and lowering cross-contamination risks. This trend is notably visible in the expansion of contract development and manufacturing organizations, which are progressively substituting traditional stainless-steel setups with flexible disposable systems to manage varied biologic pipelines. This shift enables facilities to transition between product lines more quickly, enhancing capacity usage and decreasing water consumption. Highlighting this dedication to scalable disposable infrastructure, WuXi Biologics announced in a June 2024 press release the installation of three new sets of 5,000-liter single-use bioreactors at its Hangzhou site, boosting total capacity from 8,000 to 23,000 liters to satisfy global needs.

Simultaneously, the incorporation of artificial intelligence into process optimization is changing the design and execution of purification protocols. Utilizing sophisticated machine learning algorithms allows manufacturers to forecast ideal chromatography conditions and filtration settings, greatly lessening the experimental load needed for process development. This digital evolution permits real-time monitoring and adaptive management of isolation units, guaranteeing consistent product quality and reducing yield waste. The sector's move towards these digital tools is gaining speed as firms aim to improve operations and data-based decision-making. As reported by Benchling in their '2024 State of Tech in Biopharma Report' from November 2024, 67% of major biopharmaceutical companies have embraced artificial intelligence and machine learning to upgrade their R&D capabilities.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • QIAGEN N.V
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • GE HealthCare Technologies Inc.
  • Promega Corporation
  • Norgen Biotek Corp.
  • Abcam Limited
  • Danaher Corporation

Report Scope

In this report, the Global Protein Purification and Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Purification and Isolation Market, By Application

  • Drug Screening
  • Biomarker Discovery
  • Protein-Protein
  • Interaction Studies
  • Diagnostics

Protein Purification and Isolation Market, By Product

  • Instruments
  • Consumables

Protein Purification and Isolation Market, By Technology

  • Ultrafiltration
  • Precipitation
  • Chromatography
  • Electrophoresis
  • Western Blotting
  • Others

Protein Purification and Isolation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Purification and Isolation Market.

Available Customizations:

Global Protein Purification and Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Purification and Isolation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Drug Screening, Biomarker Discovery, Protein-Protein, Interaction Studies, Diagnostics)
    • 5.2.2. By Product (Instruments, Consumables)
    • 5.2.3. By Technology (Ultrafiltration, Precipitation, Chromatography, Electrophoresis, Western Blotting, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Protein Purification and Isolation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Product
    • 6.2.3. By Technology
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Protein Purification and Isolation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Technology
    • 6.3.2. Canada Protein Purification and Isolation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Technology
    • 6.3.3. Mexico Protein Purification and Isolation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Technology

7. Europe Protein Purification and Isolation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Product
    • 7.2.3. By Technology
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Protein Purification and Isolation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Technology
    • 7.3.2. France Protein Purification and Isolation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Technology
    • 7.3.3. United Kingdom Protein Purification and Isolation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Technology
    • 7.3.4. Italy Protein Purification and Isolation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Technology
    • 7.3.5. Spain Protein Purification and Isolation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Technology

8. Asia Pacific Protein Purification and Isolation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Product
    • 8.2.3. By Technology
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Protein Purification and Isolation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Technology
    • 8.3.2. India Protein Purification and Isolation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Technology
    • 8.3.3. Japan Protein Purification and Isolation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Technology
    • 8.3.4. South Korea Protein Purification and Isolation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Technology
    • 8.3.5. Australia Protein Purification and Isolation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Technology

9. Middle East & Africa Protein Purification and Isolation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Product
    • 9.2.3. By Technology
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Protein Purification and Isolation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Technology
    • 9.3.2. UAE Protein Purification and Isolation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Technology
    • 9.3.3. South Africa Protein Purification and Isolation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Technology

10. South America Protein Purification and Isolation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Product
    • 10.2.3. By Technology
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Protein Purification and Isolation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Technology
    • 10.3.2. Colombia Protein Purification and Isolation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Technology
    • 10.3.3. Argentina Protein Purification and Isolation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Technology

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Protein Purification and Isolation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Merck KGaA
  • 15.3. QIAGEN N.V
  • 15.4. Bio-Rad Laboratories, Inc.
  • 15.5. Agilent Technologies, Inc.
  • 15.6. GE HealthCare Technologies Inc.
  • 15.7. Promega Corporation
  • 15.8. Norgen Biotek Corp.
  • 15.9. Abcam Limited
  • 15.10. Danaher Corporation

16. Strategic Recommendations

17. About Us & Disclaimer